The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
In Vitro Inhibition of the Bile Salt Export Pump Correlates with Risk of Cholestatic Drug-Induced Liver Injury in Humans
Abstract
Inhibition of the activity of the human bile salt export pump (BSEP: ABCB11) has been proposed to play a role in drug-induced liver injury (DILI). To enhance understanding of the relationship between BSEP inhibition and DILI, inhibition of human BSEP (hBSEP) and its rat ortholog (rBsep) by 85 pharmaceuticals was investigated in vitro. This was explored using assays that quantified inhibition of ATP-dependent [(3)H]taurocholate uptake into inverted plasma membrane vesicles from Sf21 insect cells, which expressed the proteins. Of the pharmaceuticals, 40 exhibited evidence of in vitro transporter inhibition and overall a close correlation was observed between potency values for inhibition of hBSEP and rBsep activity (r(2) = 0.94), although 12 drugs exhibited >2-fold more potent inhibition of hBSEP than rBsep. The median potency of hBSEP inhibition was higher among drugs that caused cholestatic/mixed DILI than among drugs that caused hepatocellular or no DILI, as was the incidence of hBSEP inhibition with IC(50) <300 μM. All drugs with hBSEP IC(50) <300 μM had molecular weight >250, ClogP >1.5, and nonpolar surface area >180Å. A clear distinction was not evident between hBSEP IC(50) or unbound plasma concentration (C(max, u)) of the drugs in humans and whether the drugs caused DILI. However, all 17 of the drugs with hBSEP IC(50) <100 μM and C(max, u) >0.002 μM caused DILI. Overall, these data indicate that inhibition of hBSEP/rBsep correlates with the propensity of numerous pharmaceuticals to cause cholestatic DILI in humans and is associated with several of their physicochemical properties.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Strautnieks, S. S., Bull, L. N., Knisely, A. S., Kocoshis, S. A., Dahl, N., Arnell, H., Sokal, E., Dahan, K., Childs, S., Ling, V., et al. (1998) · Nature Genetics · doi:10.1038/3034 · Cited by 995
Bile-acid-induced cell injury and protection
Perez, M. J., & Briz, O. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.1677 · Cited by 717
Hepatotoxicity. The adverse effects of drugs and other chemicals on the liver
(1980) · Food and Cosmetics Toxicology · doi:10.1016/0015-6264(80)90206-0 · Cited by 691
The influence of lead discovery strategies on the properties of drug candidates
Keserü, G. M., & Makara, G. M. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2796 · Cited by 628
Stieger, B., Fattinger, K., Madon, J., Kullak-Ublick, G. A., & Meier, P. J. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70224-1 · Cited by 582
Hepatotoxicity the adverse effects of drugs and other chemicals on the liver
Zimmerman, H. J. (1999) · Cited by 514
Fattinger, K. (2001) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2001.114667 · Cited by 509
Abboud, G., & Kaplowitz, N. (2007) · Drug Safety · doi:10.2165/00002018-200730040-00001 · Cited by 479
Fickert, P., Fuchsbichler, A., Wagner, M., Zollner, G., Kaser, A., Tilg, H., Krause, R., Lammert, F., Langner, C., Zatloukal, K., et al. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.04.009 · Cited by 468
Kartenbeck, J., Leuschner, U., Mayer, R., & Keppler, D. (1996) · Hepatology · doi:10.1002/hep.510230519 · Cited by 398
Cited by
Items 201–300 of 349
Fukuda, H., Nakanishi, T., & Tamai, I. (2013) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.dmpk-13-nt-049 · Cited by 12
Pathogenesis of Idiosyncratic Drug Induced Liver Injury
Dara, L., Liu, Z.-X., & Kaplowitz, N. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804274-8.00005-9 · Cited by 12
Ito, S., Lee, W., Park, J. E., Yasunaga, M., Mori, A., Ohtsuki, S., & Sugiyama, Y. (2020) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2020.10.064 · Cited by 11
Bosentan Alters Endo- and Exogenous Bile Salt Disposition in Sandwich-Cultured Human Hepatocytes
Oorts, M., Brantegem, P. V., Deferm, N., Chatterjee, S., Dreesen, E., Cooreman, A., Vinken, M., Richert, L., & Annaert, P. (2021) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.121.000695 · Cited by 11
Mouse precision-cut liver slices as an ex vivo model to study drug-induced cholestasis
Karsten, R. E. H., Krijnen, N., Maho, W., Permentier, H. P., Verpoorte, E. M. J., & Olinga, P. (2022) · Archives of Toxicology · doi:10.1007/s00204-022-03321-2 · Cited by 11
Marroquin, L. D., Bonin, P. D., Keefer, J., & Schroeter, T. (2017) · Current Protocols in Toxicology · doi:10.1002/cptx.15 · Cited by 11
Brecklinghaus, T., Albrecht, W., Duda, J., Kappenberg, F., Gründler, L., Edlund, K., Marchan, R., Ghallab, A., Cadenas, C., Rieck, A., et al. (2022) · Toxicology Letters · doi:10.1016/j.toxlet.2022.08.006 · Cited by 11
Ogimura, E., Tokizono, M., Sekine, S., Nakagawa, T., Bando, K., & Ito, K. (2017) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2017.04.050 · Cited by 11
Xi, L., Yao, J., Wei, Y., Wu, X., Yao, X., Liu, H., & Li, S. (2017) · Molecular BioSystems · doi:10.1039/c6mb00744a · Cited by 10
Structure–Activity Relationship of Novel and Selective Biaryl-Chroman GPR40 AgoPAMs
Chen, H. Y., Plummer, C. W., Xiao, D., Chobanian, H. R., DeMong, D. E., Miller, M. A., Trujillo, M. E., Kirkland, M. E., Kosinski, D. T., Mane, J., et al. (2018) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.8b00149 · Cited by 10
Current Models for Predicting Drug-induced Cholestasis: The Role of Hepatobiliary Transport System.
Jazaeri, F., Sheibani, M., Nezamoleslami, S., Moezi, L., & Dehpour, A. R. (2021) · PubMed Central · doi:10.22037/ijpr.2020.113362.14254 · Cited by 10
Ali, I., Khalid, S., Stieger, B., & Brouwer, K. L. R. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b01124 · Cited by 10
Béquignon, O. J. M., Pawar, G. V., van de Water, B., Cronin, M., & van Westen, G. J. P. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.11535-1 · Cited by 10
Yang, K., & Brouwer, K. L. R. (2014) · Drug Metabolism and Disposition · doi:10.1124/dmd.114.057190 · Cited by 10
Horiuchi, S., Kuroda, Y., Oyafuso, R., Komizu, Y., Maeda, K., & Ishida, S. (2024) · Archives of Toxicology · doi:10.1007/s00204-024-03757-8 · Cited by 9
Quantitative Kinetic Models from Intravital Microscopy: A Case Study Using Hepatic Transport
Tavakoli, M., Tsekouras, K., Day, R. N., Dunn, K. W., & Pressé, S. (2019) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.9b04729 · Cited by 9
Battista, C., Howell, B. A., Siler, S. Q., & Watkins, P. B. (2018) · Methods in pharmacology and toxicology · doi:10.1007/978-1-4939-7677-5_6 · Cited by 9
Donato, M. T., López-Riera, M., Castell, J. V., Gómez-Lechón, M. J., & Jover, R. (2016) · Toxicology Letters · doi:10.1016/j.toxlet.2016.10.008 · Cited by 9
Vée, M. L., Moreau, A., Jouan, E., Denizot, C., Parmentier, Y., & Fardel, O. (2022) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.2333 · Cited by 8
Cyanide Trapping of Iminium Ion Reactive Metabolites: Implications for Clinical Hepatotoxicity
Miao, X., Dear, G. J., Beaumont, C., Vitulli, G., Collins, G. W., Gorycki, P. D., Harrell, A. W., & Sakatis, M. Z. (2024) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.3c00402 · Cited by 8
Dvořák, Z., Vyhlídalová, B., Pečinková, P., Li, H., Anzenbacher, P., Špičáková, A., Anzenbacherová, E., Chow, V., Liu, J., Krause, H. M., et al. (2024) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2024.107137 · Cited by 8
Role of the Adaptive Immune System in Idiosyncratic Drug-Induced Liver Injury
Uetrecht, J. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-387817-5.00011-x · Cited by 8
Li, Y., Evers, R., Hafey, M. J., Cheon, K., Duong, H., Lynch, D., LaFranco-Scheuch, L., Pacchione, S. J., Tamburino, A. M., Tanis, K. Q., et al. (2019) · Toxicological Sciences · doi:10.1093/toxsci/kfz079 · Cited by 8
Wei, E., Zhang, S., Zhai, J., Wu, S., & Wang, G. (2020) · Drug and Chemical Toxicology · doi:10.1080/01480545.2020.1815763 · Cited by 8
Pharmacokinetic Drug-drug Interaction of Antibiotics Used in Sepsis Care in China
Yu, X., Chu, Z., Li, J., He, R., Wang, Y., & Cheng, C. (2020) · Current Drug Metabolism · doi:10.2174/1389200221666200929115117 · Cited by 8
Evaluation of the hepatotoxicity of the novel GPR40 (FFAR1) agonist CPL207280 in the rat and monkey
Bazydło‐Guzenda, K., Buda, P., Mach, M., Pieczykolan, J., Kozłowska, I., Janiszewski, M., Drzazga-Wilk, E., Dominowski, J., Ziółkowski, H., Wieczorek, M., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0257477 · Cited by 8
The bile salt export pump (BSEP/ABCB11)
Lai, Y. (2013) · Elsevier eBooks · doi:10.1533/9781908818287.327 · Cited by 8
Kenna, J. G. (2017) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2017.1290082 · Cited by 7
Self-citationIntegration of in vitro and in silico approaches enables prediction of drug-induced liver injury
Geci, R., Sayin, A. Z., Schaller, S., & Kuepfer, L. (2026) · Archives of Toxicology · doi:10.1007/s00204-026-04305-2 · Cited by 7
Usefulness of plasma bile acid profile as a prognostic biomarker for drug-induced liver injury
Monte, M. J., Tran, T. D., Grove, J. I., Li, D., Stephens, C. M., Lucena, M. I., Andrade, R. J., Weber, S., Gerbes, A. L., Bjornsson, E. S., et al. (2026) · EBioMedicine · doi:10.1016/j.ebiom.2026.106229 · Cited by 7
Potential Effects of Dietary Isoflavones on Drug-Induced Liver Injury
Yao, L., Nisar, M. F., Yan, T., & Wan, C. C. (2021) · Journal of Food Quality · doi:10.1155/2021/2870969 · Cited by 7
Tóth, B., Krajcsi, P., & Magnan, R. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-404630-6.00056-7 · Cited by 7
Li, Y., Yan, D., Jin, J., Tan, B., Chen, X., Zou, B., Song, G., Weng, F., Liu, C., & Qiu, F. (2022) · Toxicology in Vitro · doi:10.1016/j.tiv.2022.105324 · Cited by 7
Umemori, Y., Handa, K., Yoshimura, S., Kageyama, M., & Iijima, T. (2024) · Biomolecules · doi:10.3390/biom14050535 · Cited by 6
Chutia, H., Borah, G. S., Mahanta, H. J., & Nagamani, S. (2025) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.4c00532 · Cited by 6
ABC gene-ranking for prediction of drug-induced cholestasis in rats
Cherkas, Y., McMillian, M., Amaratunga, D., Raghavan, N., & Sasaki, J. C. (2016) · Toxicology Reports · doi:10.1016/j.toxrep.2016.01.009 · Cited by 6
Light, D. S., Aleo, M. D., & Kenna, J. G. (2018) · Methods in pharmacology and toxicology · doi:10.1007/978-1-4939-7677-5_17 · Cited by 6
Self-citationKastrinou‐Lampou, V., Rodríguez-Pérez, R., Poller, B., Huth, F., Gáborik, Z., Mártonné-Tóth, B., Temesszentandrási‐Ambrus, C., Schadt, H. S., Kullak-Ublick, G. A., Arand, M., et al. (2024) · Archives of Toxicology · doi:10.1007/s00204-024-03794-3 · Cited by 6
Matsui, T., Miyamoto, N., Saito, F., & Shinozawa, T. (2020) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201021666200422090952 · Cited by 6
Ferslew, B. C., Köck, K., & Brouwer, K. L. R. (2014) · Wiley eBooks · doi:10.1002/9781118705308.ch13 · Cited by 6
Hepatic Apoptosis and Necrosis
Xia, F., Zeng, L., Yao, X., & Zhou, B. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804274-8.00003-5 · Cited by 6
Requirements for designing organ-on-a-chip platforms to model the pathogenesis of liver disease
Ishida, S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-817202-5.00005-x · Cited by 6
Maerten, A., Callewaert, E., Sanz-Serrano, J., Devisscher, L., & Vinken, M. (2025) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2025.180975 · Cited by 5
Toroz, D., Khanna, T., & Gould, I. R. (2019) · ACS Omega · doi:10.1021/acsomega.8b02271 · Cited by 5
Drug-Induced Liver Injury: Mechanism-Informed Prediction in Drug Development
Goldring, C. E., Weaver, R. J., Kramer, B. A., Klingmüller, U., Oppelt, A.-S., der Water, B. V., Commandeur, J. N. M., Guillouzo, A., Naisbitt, D. J., French, N. S., et al. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-409547-2.12384-4 · Cited by 5
Physicochemical Properties and Structural Alerts
Fisk, L., Greene, N., & Naven, R. T. (2018) · Methods in pharmacology and toxicology · doi:10.1007/978-1-4939-7677-5_4 · Cited by 5
Detection of Drug-Induced Cholestasis Potential in Sandwich-Cultured Human Hepatocytes
Deferm, N., Richert, L., Brantegem, P. V., Vocht, T. D., Qi, B., de Witte, P. A. M., Bouillon, T. W., & Annaert, P. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9420-5_22 · Cited by 5
Utilizing in vitro transporter data in IVIVE-PBPK: an overview
Mallick, P. (2017) · ADMET & DMPK · doi:10.5599/admet.5.4.441 · Cited by 5
Li, Y., & Zhou, H. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00008-6 · Cited by 5
Transporter study methodologies
Lai, Y. (2013) · Elsevier eBooks · doi:10.1533/9781908818287.675 · Cited by 5
ABSTRACTS FROM THE 10 TH INTERNATIONAL ISSX MEETING
(2014) · Drug Metabolism Reviews · doi:10.3109/03602532.2013.868114 · Cited by 5
Drug‐Induced Hepatotoxicity: Advances in Preclinical Predictive Strategies and Tools
Dambach, D. M. (2014) · Predictive ADMET · doi:10.1002/9781118783344.ch19 · Cited by 4
Alteration of bile acid composition is a possible risk factor for antibiotics-induced liver injury
Takemura, A., Suminoe, S., Hirai, T., Nakasone, K., Hayasaki, K., Song, B., & Ito, K. (2025) · The Journal of Toxicological Sciences · doi:10.2131/jts.50.379 · Cited by 4
Advanced human liver models for the assessment of drug-induced liver injury
Mun, S. J., Lee, J., Shin, Y., & Son, M. J. (2022) · Organoid · doi:10.51335/organoid.2022.2.e17 · Cited by 4
Role of Membrane Transport in Hepatotoxicity and Pathogenesis of Drug-Induced Cholestasis
Stieger, B., & Kullak-Ublick, G. A. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-387817-5.00007-8 · Cited by 4
Kastrinou‐Lampou, V., Rodríguez-Pérez, R., Poller, B., Huth, F., Schadt, H. S., Kullak-Ublick, G. A., Arand, M., & Camenisch, G. (2024) · Archives of Toxicology · doi:10.1007/s00204-024-03895-z · Cited by 4
Vesicle- and Hepatocyte-Based Assays for Identification of Drug Candidates Inhibiting BSEP Function
Brantegem, P. V., Deferm, N., Qi, B., Vocht, T. D., & Annaert, P. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9420-5_4 · Cited by 4
Metabophore-mediated retro-metabolic (‘MeMeReMe’) approach in drug design
Balaji, S. (2023) · Drug Discovery Today · doi:10.1016/j.drudis.2023.103736 · Cited by 4
How Open Data Shapes In Silico Transporter Modeling
Montanari, F., & Zdrazil, B. (2017) · Molecules · doi:10.3390/molecules22030422 · Cited by 4
ATP-Binding-Cassette Transporters in Biliary Efflux and Drug-Induced Liver Injury
Pedersen, J. M. (2013) · KTH Publication Database DiVA (KTH Royal Institute of Technology) · Cited by 4
Sjöstedt, N., Amaeze, O. U., van den Heuvel, J. J. M. W., Stage, T. B., Koenderink, J. B., Isoherranen, N., Kidron, H., & Järvinen, E. (2026) · Clinical and Translational Science · doi:10.1111/cts.70487 · Cited by 3
Beyond the Pump: The Evolving Molecular Landscape of Intrahepatic Cholestasis
Ziccardi, Zorzi, M., & D’Adamo, P. (2026) · Diagnostics · doi:10.3390/diagnostics16050726 · Cited by 3
Guo, H., Yu, H., Zu, H., Cui, J., Ding, H., Xia, Y., Chen, D., Zeng, Y., Wang, Y., Wang, Y., et al. (2023) · Toxicology Letters · doi:10.1016/j.toxlet.2023.06.003 · Cited by 3
3D hepatic organoid production from human pluripotent stem cells
Jin, Z., Xu, K., Kim, J., Guo, H., Yao, X., Li, Y., Li, Y.-H., Ryu, D., Kim, K.-P., Hong, K., et al. (2023) · Differentiation · doi:10.1016/j.diff.2023.100742 · Cited by 3
Fardel, O., Moreau, A., Jouan, E., Denizot, C., Vée, M. L., & Parmentier, Y. (2025) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2025.2453486 · Cited by 3
Wu, Z., Yao, D., Ji, S., Ni, X., Gao, Y., Hui, L., & Pan, G. (2016) · Cellular Physiology and Biochemistry · doi:10.1159/000443120 · Cited by 3
Liu, S., Liu, X., Jiang, S., Fu, M., Hu, J., Liu, J., Fan, X., Feng, Y., Zhang, S., & Wang, J. (2023) · Journal of Traditional Chinese Medical Sciences · doi:10.1016/j.jtcms.2023.12.005 · Cited by 3
Kenna, J. G., Persson, M., Siler, S. Q., Yu, K., Hu, C., Chen, M., Xu, J., Tong, W., Will, Y., & Aleo, M. D. (2016) · Wiley eBooks · doi:10.1002/9781119053248.ch8 · Cited by 3
Self-citationAbza, G. B., Vos, K. D., & Annaert, P. (2025) · Xenobiotica · doi:10.1080/00498254.2025.2475501 · Cited by 2
Physicochemistry and the Off‐Target Effects of Drug Molecules
Smith, D. A. (2016) · Wiley eBooks · doi:10.1002/9781119053248.ch5 · Cited by 2
Leading-Edge Approaches for In Vitro Hepatotoxicity Evaluation
LeCluyse, E. L., Norona, L. M., Akingbasote, J. A., Howell, L. S., Woodhead, J. L., Cross, M. J., Roth, A. B., & Goldring, C. E. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.64267-8 · Cited by 2
Drug Interactions in the Liver
Aithal, G. P., & Kullak-Ublick, G. A. (2020) · Wiley eBooks · doi:10.1002/9781119436812.ch82 · Cited by 2
Colestasis inducida por anabólicos: reporte de caso y revisión de la literatura
Cabrera-Rojas, D. L., Soto-Cardona, J., Toro-Molina, J. L., Cadavid, J. C. P., & Marín, J. I. (2021) · Hepatología · doi:10.52784/27112330.134 · Cited by 2
Regulatory Science Perspectives on Transporter Studies in Drug Development
Lee, S., Zhang, L., & Huang, S. M. (2014) · Wiley eBooks · doi:10.1002/9781118705308.ch23 · Cited by 2
The Discovery of Macitentan – A Standard Medicinal Chemistry Program?
Bolli, M. H. (2017) · CHIMIA International Journal for Chemistry · doi:10.2533/chimia.2016.420 · Cited by 2
ABC Transporters: From Targets to Antitargets and Back
Ecker, G. F. (2017) · Methods and principles in medicinal chemistry · doi:10.1002/9783527679430.ch5 · Cited by 2
Bile Salt Export Pump: Drug-Induced Liver Injury and Assessment Approaches
Deng, R. (2018) · Methods in pharmacology and toxicology · doi:10.1007/978-1-4939-7677-5_15 · Cited by 2
Rifaldi, M., Lintong, P. M., & Durry, M. F. (2016) · Jurnal e-Biomedik · doi:10.35790/ebm.4.2.2016.14657 · Cited by 2
The study of troglitazone liver toxicity via in vitro and in silico approaches
Nuamah, M. F. (2022) · Nottingham ePrints (University of Nottingham) · Cited by 2
In Vitro Assay System to Detect Drug-Induced Bile Acid-Dependent Cytotoxicity Using Hepatocytes
Takemura, A., & Ito, K. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2557-6_8 · Cited by 1
Tran, A. T., Crawford, J. J., Mandal, D., Güney, T., & Karmel, J. (2023) · Medicinal chemistry reviews · doi:10.1021/mc-2023-vol58.ch19 · Cited by 1
Yoon, J., Song, H., Park, J. S., Kim, J. H., Jun, Y., Gim, S.-A., Hong, C., An, K. M., Park, J.-T., Lee, J. W., et al. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117674 · Cited by 1
Modulating the Gut Microbiota to Combat Drug-Induced Liver Injury: A New Frontier in Hepatic Health
Ye, Y., & Chu, H. (2025) · IntechOpen eBooks · doi:10.5772/intechopen.1009178 · Cited by 1
Takemura, A., Naito, S., Higuchi, Y., Uehara, S., Yoneda, N., Suemizu, H., & Ito, K. (2026) · Drug Metabolism and Pharmacokinetics · doi:10.1016/j.dmpk.2026.101530 · Cited by 1
Alberola, I. D., Zeo-Sánchez, D. E. D., Garrido‐Rodríguez, V., Gomez, C. L., Rodriguez‐Diaz, C., Andrade, R. J., Lucena, M. I., Paz, M. V., & García‐Fuentes, E. (2026) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2026.04.014 · Cited by 1
Maciejewski, M., Lounkine, E., Hartmann, A., Whitebread, S., & Urbán, L. (2015) · Methods and principles in medicinal chemistry · doi:10.1002/9783527673643.ch03 · Cited by 1
Testa, A., Dall’Angelo, S., Mingarelli, M., Augello, A., Schweiger, L. F., Welch, A. E., Elmore, C. S., Dawson, D. K., Sharma, P. K., & Zanda, M. (2018) · Contrast Media & Molecular Imaging · doi:10.1155/2018/3064751 · Cited by 1
Mechanism‐Based Experimental Models for the Evaluation of BSEP Inhibition and DILI
Murphy, W. A., Saran, C., Honkakoski, P., & Brouwer, K. L. R. (2021) · Wiley eBooks · doi:10.1002/9781119171003.ch9 · Cited by 1
The Discovery of Macitentan—A Standard Medicinal Chemistry Program?
Bolli, M. H., Boss, C., Gatfield, J., Iglarz, M., & Treiber, A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-409547-2.12455-2 · Cited by 1
Current Social, Clinical, and Scientific Environment of Pharmaceutical R&D
Urbán, L., Valentin, J., Kaitin, K. I., & Wang, J. (2014) · Wiley eBooks · doi:10.1002/9781118783344.ch1 · Cited by 1
INTEGRATED REACTIVE METABOLITE STRATEGIES
Kenna, J. G., & Thompson, R. A. (2016) · Wiley eBooks · doi:10.1002/9781118949689.ch5 · Cited by 1
Self-citationKalgutkar, A. S. S. (2021) · Royal Society of Chemistry eBooks · doi:10.1039/9781788016414-00314 · Cited by 1
Sjöstedt, N., Adiwidjaja, J., Murphy, W. A., & Brouwer, K. L. R. (2022) · Wiley eBooks · doi:10.1002/9781119739883.ch13 · Cited by 1
How to reduce risk of drug induced liver toxicity from the beginning
Gan, J., He, K., & Humphreys, W. G. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-817134-9.00010-6 · Cited by 1
Karsten, R. E. H., Gier, K., de Meijer, V. E., Huibers, W. H. C., Permentier, H. P., Verpoorte, E. M. J., & Olinga, P. (2025) · Toxicology in Vitro · doi:10.1016/j.tiv.2025.106011 · Cited by 1
Functional and Structural Studies of the Human Bile Salt Export Pump (BSEP)
Lancien, L. (2019) · Repository for Publications and Research Data (ETH Zurich) · doi:10.3929/ethz-b-000331483 · Cited by 1
Chan, R. H. M. (2017) · eScholarship (California Digital Library) · Cited by 1
Slizgi, J. R. (2017) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/v0kz-1a18 · Cited by 1
Stieger, B., & Kullak-Ublick, G. A. (2015) · Methods and principles in medicinal chemistry · doi:10.1002/9783527673643.ch08
Mechanistic Modeling of Drug‐Induced Liver Injury (DILI)
Yang, K., Woodhead, J. L., Shoda, L. K. M., Yang, Y., Watkins, P. B., Brouwer, K. L. R., Howell, B. A., & Siler, S. Q. (2015) · Methods and principles in medicinal chemistry · doi:10.1002/9783527673643.ch09
Metadata
- Authors
- Dawson, S., Stahl, S., Paul, N., Barber, J., & Kenna, J. G.
- Affiliations
- AstraZeneca (United Kingdom) (GB)
- Venue
- Drug Metabolism and Disposition
- Publisher
- Elsevier BV
- Published
- 2012-01
- Volume
- 40
- Issue
- 1
- Pages
- 130-138
- ISSN
- 0090-9556 (ISSN-L)
- OpenAlex
- W2134837921
- Semantic Scholar
- 60ba71aac3cdfdcd69699825099b32f2949b1f89
- Cited by
- 343
- References
- 49
- Citations by year
- 2026: 18 · 2025: 13 · 2024: 10 · 2023: 9 · 2022: 20 · 2021: 16 · 2020: 20 · 2019: 25 · 2018: 25 · 2017: 43 · 2016: 40 · 2015: 27 · 2014: 28 · 2013: 35 · 2012: 13
- FWCI
- 11.83
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Locations
- Drug Metabolism and Disposition (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Keywords
- bile salt export pump, ABCB11, drug-induced liver injury, cholestatic liver injury, transporter inhibition, taurocholate uptake, physicochemical properties, drug safety prediction, hepatotoxicity
- MeSH terms
- ATP Binding Cassette Transporter, Subfamily B, Member 11, Animals, Bile Acids and Salts, Cell Line, Cholestasis, Humans, Insecta, Risk Factors, ATP-Binding Cassette Transporters, Rats, Chemical and Drug Induced Liver Injury, Drug-Related Side Effects and Adverse Reactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.